Vanguard Group Inc Adamis Pharmaceuticals Corp Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.14 - $0.22 $455 - $716	3,257 Added 0.05%	6,483,945 $1.1 Million
Q1 2022 May 13, 2022	SELL	$0.55 - $0.73 $20,992 - $27,862	-38,168 Reduced 0.59%	6,480,688 $3.7 Million
Q4 2021 Feb 14, 2022	BUY	$0.57 - $1.23 $5,359 - $11,564	9,402 Added 0.14%	6,518,856 $3.94 Million
Q3 2021 Nov 12, 2021	BUY	$0.92 - $1.18 $179,963 - $230,823	195,613 Added 3.1%	6,509,454 $6.32 Million
Q2 2021 Aug 13, 2021	BUY	$0.66 - $1.23 $4.17 Million - $7.77 Million	6,313,841 New	6,313,841 $6.95 Million

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.